NCT01435395 2016-04-27Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma MultiformeEmory UniversityPhase 1 Completed12 enrolled
NCT00544284 2013-02-15Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to TreatmentCity of Hope Medical CenterPhase 1 Completed25 enrolled
NCT00006773 2013-01-24Bortezomib in Treating Patients With Recurrent GliomaNational Cancer Institute (NCI)Phase 1 Terminated42 enrolled